BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., has appointed John P. Gorst as Chief Executive Officer, effective immediately, as the company advances toward closing its acquisition of Ancient Extracts USA and pursues broader platform expansion. Jordan P. Balencic, who previously served as CEO, will remain Chairman and transition into the role of Chief Science Officer, focusing on strategic growth, product development, and commercialization.
Mr. Gorst brings more than 30 years of experience in public company leadership, consumer products, manufacturing, and capital markets. According to the company, he has participated in raising over $100 million through equity financings, PIPE transactions, and debt offerings, and has been involved in two eight-figure business exits. Management expects Mr. Gorst to drive operational execution, acquisition integration, and fundraising efforts as BFCH builds its wellness platform.
The appointment comes as BFCH works to finalize definitive agreements for the acquisition of Ancient Extracts USA, a post-revenue wellness platform with direct-to-consumer infrastructure, a growing customer base, and active commercialization initiatives. Management anticipates announcing initial purchase orders and commercial developments following the closing.
“What excites me most is how naturally all of this fits together,” said Dr. Balencic. “Ancient Extracts USA already has a commercial foundation in place, and Mr. Gorst brings decades of operational, manufacturing, consumer products, and capital markets experience. Our skill sets complement each other extremely well, and we are already identifying multiple opportunities to expand the platform, create strategic synergies, and accelerate growth.”
Mr. Gorst is expected to join the Board of Directors as part of the company’s effort to expand its governance infrastructure. He will also initiate the formation of audit and compensation committees to prepare for future audits and support the recruitment of additional C-level executives.
“What attracted me to BFCH is that this is more than a turnaround story,” Mr. Gorst said. “Ancient Extracts USA already has products, customers, revenue, infrastructure, and momentum in place. I believe there is a significant opportunity to scale the platform through disciplined execution, expanded distribution, strategic partnerships, and additional operating assets.”
BFCH continues to evaluate additional acquisition opportunities and strategic partnerships aligned with its focus on consumer wellness, functional products, and human optimization. For more information, visit www.UNLOCKDinc.com and view filings on OTC Markets.
